Apollo Endosurgery (APEN) Misses Q3 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 falls from record high as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Apollo Endosurgery, Inc. Reports Third Quarter 2018 Results
November 8, 2018 4:00 PM ESTConference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET
AUSTIN, Texas--(BUSINESS WIRE)-- Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced financial results for the third quarter ended September 30, 2018.
Third Quarter 2018 Highlights
ESS contributed 37% of total sales in the quarter U.S. ESS sales increased 24% year-over-year in the quarter and 34% in the first nine months of 2018 Worldwide ESS sales increased 40% in the first nine... More